Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jenny, Nobes"'
Publikováno v:
Oncology and Therapy, Vol 11, Iss 3, Pp 291-301 (2023)
Abstract This article was co-authored by a patient’s relative describing their experiences of receiving a diagnosis and subsequent clinical management of a rare form of prostate cancer, neuroendocrine prostate cancer (NEPC). The difficulty of recei
Externí odkaz:
https://doaj.org/article/a48d1a2403c94bd1a36dc44d22ee5267
Autor:
Iris Bartula, Anh D. Tran, Anna K. Nowak, Tasnia Ahmed, Rachael L. Morton, Bryan H. Burmeister, Kari Dolven-Jacobsen, Jenny Nobes, John F. Thompson, Gerald B. Fogarty, Serigne N Lo, Angela M. Hong
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 41, Iss , Pp 100597- (2023)
Purpose: Brain metastases are common in patients with advanced melanoma. This study describes 12-month quality of life (QoL) trajectories following local management of 1–3 melanoma brain metastases. Methods: This study assessed QoL data collected d
Externí odkaz:
https://doaj.org/article/514f4cda73254eaf961d437c1dc982c4
Autor:
Yun Song, John F Thompson, Frances A Collichio, Tasha Hughes, John Vetto, Dale Han, Jonathan Zager, Zeynep Eroglu, Jennifer Downs, David E Gyorki, Nikhil I Khushalani, Alexander van Akkooi, Georgia Beasley, Lisa Kottschade, Hidde M Kroon, Ann Lee, Norma E Farrow, Giorgos Karakousis, Michael Lowe, Avinash Sharma, Kristy K Broman, Amanda Nijhuis, Tina J Hieken, Jeffrey M Farma, Meghan Hotz, Jeremiah Deneve, Martin Fleming, Edmund K Bartlett, Lesly Dossett, Russell S Berman, Emma Stahlie, Jane Yuet Ching Hui, Marc Moncrieff, Jenny Nobes, Kirsten Baecher, Matthew Perez, David W Ollila, Roger Olofsson Bagge, Jan Mattsson, Harvey Chai, Jyri Teras, James Sun, Michael J Carr, Ankita Tandon, Nalan Akgul Babacan, Younchul Kim, Mahrukh Naqvi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 8 (2022)
Until recently, most patients with sentinel lymph node-positive (SLN+) melanoma underwent a completion lymph node dissection (CLND), as mandated in published trials of adjuvant systemic therapies. Following multicenter selective lymphadenectomy trial
Externí odkaz:
https://doaj.org/article/5e2609c2e5e44274aabf900f1ff2c1c7
Autor:
Kristy K, Broman, Tasha M, Hughes, Brooke C, Bredbeck, James, Sun, Dennis, Kirichenko, Michael J, Carr, Avinash, Sharma, Edmund K, Bartlett, Amanda A G, Nijhuis, John F, Thompson, Tina J, Hieken, Lisa, Kottschade, Jennifer, Downs, David E, Gyorki, Emma, Stahlie, Alexander, van Akkooi, David W, Ollila, Kristin, O'shea, Yun, Song, Giorgos, Karakousis, Marc, Moncrieff, Jenny, Nobes, John, Vetto, Dale, Han, Meghan, Hotz, Jeffrey M, Farma, Jeremiah L, Deneve, Martin D, Fleming, Matthew, Perez, Kirsten, Baecher, Michael, Lowe, Roger Olofsson, Bagge, Jan, Mattsson, Ann Y, Lee, Russell S, Berman, Harvey, Chai, Hidde M, Kroon, Juri, Teras, Roland M, Teras, Norma E, Farrow, Georgia M, Beasley, Jane Yuet Ching, Hui, Lukas, Been, Schelto, Kruijff, Brandy, Sinco, Amod A, Sarnaik, Vernon K, Sondak, Jonathan S, Zager, Lesly A, Dossett
Publikováno v:
Annals of Surgery. 277(5):1106-1115
Objective: The aim of this study was to determine overall trends and center-level variation in utilization of completion lymph node dissection (CLND) and adjuvant systemic therapy for sentinel lymph node (SLN)-positive melanoma. Summary Background Da
Autor:
Zeynep Eroglu, Kristy K Broman, John F Thompson, Amanda Nijhuis, Tina J Hieken, Lisa Kottschade, Jeffrey M Farma, Meghan Hotz, Jeremiah Deneve, Martin Fleming, Edmund K Bartlett, Avinash Sharma, Lesly Dossett, Tasha Hughes, David E Gyorki, Jennifer Downs, Giorgos Karakousis, Yun Song, Ann Lee, Russell S Berman, Alexander van Akkooi, Emma Stahlie, Dale Han, John Vetto, Georgia Beasley, Norma E Farrow, Jane Yuet Ching Hui, Marc Moncrieff, Jenny Nobes, Kirsten Baecher, Matthew Perez, Michael Lowe, David W Ollila, Frances A Collichio, Roger Olofsson Bagge, Jan Mattsson, Hidde M Kroon, Harvey Chai, Jyri Teras, James Sun, Michael J Carr, Ankita Tandon, Nalan Akgul Babacan, Younchul Kim, Mahrukh Naqvi, Jonathan Zager, Nikhil I Khushalani
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e004417
Until recently, most patients with sentinel lymph node-positive (SLN+) melanoma underwent a completion lymph node dissection (CLND), as mandated in published trials of adjuvant systemic therapies. Following multicenter selective lymphadenectomy trial
Autor:
Amanda Ag Nijhuis, James Sun, John T. Vetto, Schelto Kruijff, Jenny Nobes, Norma E. Farrow, Russell S. Berman, Michael J Carr, Michael C. Lowe, Lisa A. Kottschade, Amod A. Sarnaik, Matthew C. Perez, Lukas B. Been, Alexander C.J. van Akkooi, Tasha M. Hughes, Ann Y. Lee, David W. Ollila, Edmund K. Bartlett, David Boulware, Jüri Teras, Hidde M. Kroon, Jeffrey M. Farma, Marc Moncrieff, Jonathan S. Zager, Yun Song, Jane Yc Hui, Tina J. Hieken, David E. Gyorki, Martin D. Fleming, Kristy K. Broman, Giorgos C. Karakousis, Lesly A. Dossett, Jan Mattsson, Dennis A Kirichenko, Jeremiah L. Deneve, Dale Han, Jennifer Downs, Georgia M. Beasley, Kirsten M Baecher, Harvey Chai, John F. Thompson, Roger Olofsson Bagge, Jill S. Frank, Vernon K. Sondak, Avinash Sharma, Roland M. Teras, Emma H. A. Stahlie
Publikováno v:
Journal of the american college of surgeons, 232(4), 424-431. ELSEVIER SCIENCE INC
Background: In sentinel lymph node (SLN)-positive melanoma, two randomized trials demonstrated equivalent melanoma-specific survival with nodal surveillance vs completion lymph node dissection (CLND). Patients with microsatellites, extranodal extensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bef2f9c0bbdaccc7182dcea4c2d35c29
https://research.rug.nl/en/publications/79ae968e-8f0b-4b47-861f-6dbc4851e58e
https://research.rug.nl/en/publications/79ae968e-8f0b-4b47-861f-6dbc4851e58e
Autor:
Matthew C. Perez, Michael C. Lowe, Hidde M. Kroon, Jan Mattsson, Amod A. Sarnaik, Jeremiah L. Deneve, Giorgos C. Karakousis, Jonathan S. Zager, Vernon K. Sondak, Harvey Chai, Jüri Teras, Tasha M. Hughes, Schelto Kruijff, Marc Moncrieff, James Sun, John T. Vetto, Syeda Mahrukh Hussnain Naqvi, Roger Olofsson Bagge, Avinash Sharma, Jenny Nobes, Jennifer Downs, Norma E. Farrow, Lisa A. Kottschade, David E. Gyorki, Dennis A Kirichenko, Jane Yuet Ching Hui, Jeffrey M. Farma, Martin D. Fleming, Kristy K. Broman, Young-Chul Kim, John F. Thompson, Lukas B. Been, Ann Y. Lee, Lesly A. Dossett, Dale Han, Jill S. Frank, Georgia M. Beasley, Alexander C.J. van Akkooi, David W. Ollila, Tina J. Hieken, Amanda A. G. Nijhuis, Yun Song, Edmund K. Bartlett, Russell S. Berman, Michael J Carr, Emma H. A. Stahlie, Roland M. Teras
Publikováno v:
Cancer, 127(13), 2251-2261. Wiley
Background For patients with sentinel lymph node (SLN)-positive cutaneous melanoma, the Second Multicenter Selective Lymphadenectomy trial demonstrated equivalent disease-specific survival (DSS) with active surveillance using nodal ultrasound versus
Autor:
Corran Roberts, Adelyn Wise, Charles Kelly, Carie Corner, Finn Tysoe, J. Lester, Martha Woodward, Avinash Gupta, Ernie Marshall, Sharon Love, Jenny Nobes, L Collins, M Goff, Mark R. Middleton, Amanda Salisbury, Virginia Wolstenholme
Publikováno v:
British Journal of Cancer
Background: Brain metastases occur in up to 75% of patients with advanced melanoma. Most are treated with whole-brain radiotherapy (WBRT), with limited effectiveness. Vandetanib, an inhibitor of vascular endothelial growth factor receptor, epidermal
Autor:
Laszlo Igali, Ed Rytina, Anna L. Paterson, Jenny Nobes, Richard Clark, Marc Moncrieff, Joseph Goodwill, Michelle Chin I Lo, Jennifer Garioch, Jane Maraka
Publikováno v:
British Journal of Cancer
Background: Determining the BRAF mutation status of patients with advanced metastatic melanoma is essential in order to assess patients' eligibility for targeted BRAF inhibitor therapy. The aim of this study was to validate the utility of immunohisto
Publikováno v:
Clinical Oncology. 32:e134